Delivery Order SPE2DR25D3306-SPE2DR26F5F0D
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,230.88 firm fixed-price delivery order by the Defense Logistics Agency on December 8, 2025, for IPOL vial 5ML (inactivated polio vaccine). This competitive award, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,094.49 for IPOL vials (5mL) on July 15, 2025, with completion expected by July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $2,180.20 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed price, non-competitive delivery order with a completion date of May 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under a larger vehicle—AmerisourceBergen's Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for IPOL vial 5ML, an inactivated polio vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- This delivery order, valued at $72,979.90 with an ultimate completion date of November 3, 2025, was awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML, a polio vaccine product. The contract employs firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in...
- The Defense Logistics Agency awarded a $53.6K delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999M and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,441.60 to AmerisourceBergen Drug Corp for IPOL Vial 5ML, an inactivated polio vaccine product. Issued on April 24, 2025, with completion scheduled for April 25, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3306Indefinite Delivery Contract
- SPE2DR25D3306-SPE2DR26F5F0DDelivery Order
The Defense Logistics Agency awarded a $10,413.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IPOL Vial 5ML, a polio vaccine product. This non-set-aside award was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This IPOL vaccine delivery order exemplifies the company's ongoing role in fulfilling immunization requirements for federal medical supply needs through DLA's Troop Support Medical program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 11/30/25 |